Neuropathological and Clinical Phenotype of an Italian Alzheimer Family with M239V Mutation of Presenilin 2 Gene

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 3, 2004, Pages 199-209

  Marcon, Gabriella ^a,b   Giaccone, Giorgio ^a   Cupidi, Chiara ^a   Balestrieri, Matteo ^b   Beltrami, Carlo Alberto ^b   Finato, Nicoletta ^b   Bergonzi, Paolo ^b   Sorbi, Sandro ^c   Bugiani, Orso ^a   Tagliavini, Fabrizio ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alzheimer disease; A ; Ectopic neurons; Epilepsy; Ghost tangles; Mutation; Presenilin 2

Indexed keywords

AMYLOID BETA PROTEIN; METHIONINE; PRESENILIN 2; VALINE;

ADULT; AGED; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; EPILEPSY; FAMILIAL DISEASE; FAMILY STUDY; FEMALE; GENE MUTATION; HUMAN; MALE; MUTATIONAL ANALYSIS; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; ONSET AGE; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; SEGREGATION ANALYSIS; WHITE MATTER;

EID: 12144289945     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.3.199     Document Type: Article

References (46)

1. St. George-Hyslop PH. Molecular genetics of Alzheimer disease. Semin Neurol 1999;19:371-83
2. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-60
3. Levy-Lahad E, Wijsman EM, Nemens E, et al. A familial Alzheimer's disease locus on chromosome 1. Science 1995;269:970-73
4. Takao M, Ghetti B, Murrel JR, et al. Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures. J Neuropathol Exp Neurol 2001;60:1137-52
5. Cruts M, van Duijn CM, Backhovens H, et al. Estimation of the genetic contribution of presenil-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 1998;7:43-51
6. Finckh U, Muller-Thomsen T, Mann U, et al. High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes. Am J Hum Genet 2000;66:110-17
7. Lao JI, Beyer K, Fernandez-Novoa L, Cacabelos R. A novel mutation in the predicted TM2 domain of the presenilin 2 gene in a Spanish patient with late-onset Alzheimer's disease. Neurogenetics 1998;1:293-96
8. Lléo A, Blesa R, Querald R, et al. Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer's disease in Spain. Arch Neurol 2002;59:1759-63
9. Lléo A, Blesa R, Gendre J, et al. A novel presenilin 2 gene mutation (D439) in a patient with early-onset Alzheimer's disease. Neurology 2001;57:1926-28
10. Rogaev EI, Sherrington R, Rogaeva EA, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:775-78
11. Finckh U, Alberici A, Antoniazzi M, et al. Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I. Neurology 2000;54:2006-8
12. Sorbi S, Tedde A, Nacmias B, et al. Novel presenilin 1 and presenilin 2 mutations in early-onset Alzheimer's disease families [abstract]. Neurobiol Aging 2002;23:S312-313
13. Sherrington R, Froelich S, Sorbi S, et al. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet 1996;5:985-88
14. Bird TD, Lampe TH, Nemens EJ, Miner GW, Sumi SM, Schellemberg GD. Familial Alzheimer's disease in American descendants of the Volga Germans: Probable genetic founder effect. Ann Neurol 1988;23:25-31
15. Bird TD, Sumi SM, Nemens EJ, et al. Phenotypic heterogeneity in familial Alzheimer's disease: A study of 24 kindreds. Ann Neurol 1989;25:12-25
16. Mann DMA, Iwatsubo T, Nochlin D, Sumi SM, Lewy-Lahad E, Bird TD. Amyloid (Aβ) deposition in chromosome 1-linked Alzheimer's disease: The Volga German families. Ann Neurol 1997;41:52-57
17. Nochlin D, Bird TD, Nemens EJ, Ball MJ, Sumi SM. Amyloid angiopathy in a Volga German family with Alzheimer's disease and a Presenilin-2 mutation (N141I). Ann Neurol 1998;43:131-35
18. Jimenez-Huete A, Alfonso P, Soto C, et al. Antibodies directed to the carboxyl terminus of amyloid β-peptide recognise sequence epitopes and distinct immunoreactive deposits in Alzheimer's disease brain. Alzheimer Report 1998;1:41-48
19. Carmel G, Mager EM, Binder LI, Kuret J. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem 1996;271:32789-95
20. Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995;189:167-69
21. Buèe-Scherrer V, Condamines O, Mourton-Gilles C, et al. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Brain Res Mol Brain Res 1996;39:79-88
22. Piccardo P, Mirra SS, Young K, Gearing M, Dlouhy SR, Ghetti B. α-Synuclein accumulation in Gerstmann-Sträussler-Scheinker disease (GSS) with prion protein gene (PRNP) mutation F198S. Neurobiol Aging 1998;19:S172
23. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCS-ADRDA Work Group under Auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44
24. Balestrieri M, Nacmias B, Sorbi S, Marcon G. Are premorbid personality traits linked to the risk of Alzheimer disease? A case series of subjects with familial mutation. Psychother Psychosom 2000;69:335-38
25. Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assesment of Alzheimer's disease. Neurology 1991;41:479-86
26. Braak H, Braak E. Neuropathological stageing of Alzheimer related changes. Acta Neuropathol 1991;82:239-59
27. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assesment of Alzheimer's Disease. Consensus recomendations for the post-mortem diagnosis for Alzheimer's disease. Neurobiol Aging 1997;18(Suppl 4):S1-2
28. Nacmias B, Marcon G, Tedde A, et al. Implication of alpha1-antichymotripsin polymorphism in familial AD. Neurosci Lett 1998;244:85-88
29. Bird TD, Levy-Lahad E, Poorkaj P, et al. Wide range in age of onset for chromosome 1-related familial Alzheimer's disease. Ann Neurol 1996;40:932-36
30. Axelman K, Basun H, Lannfelt L. Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the Presenilin-1 gene. Arch Neurol 1998;55:698-702
31. Wisniewski T, Dowjat WK, Buxbaum JD, et al. A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years. Neuroreport 1998;9:217-21
32. Taddei K, Kwok JB, Kril JJ, et al. Two novel presenil-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's disease. Neuroreport 1998;9:3335-39
33. Gomez-Isla T, Growdon WB, McNamara MJ, et al. The impact of different presenilin 1 and presenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain. Evidence for other phenotype-modifying factors. Brain 1999;122:1709-19
34. Ishii K, Lippa C, Tomiyama T, et al. Distinguishable effects of Presenilin-1 and APP717 mutations on amyloid plaque deposition. Neurobiol Aging 2001;22:367-76
35. Lemere CA, Lopera F, Kosik KS, et al. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nature Medicine 1996;2:1146-50
36. Mann DM, Pickering-Brown SM, Takeuchi A, Iwatsubo T, Members of the Familial Alzheimer's Disease Pathology Study Group. Amyloid angiopathy and variability in amyloid β deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. Am J Pathol 2001;158:2165-75
37. Hartmann D, De Strooper B, Saftig B. Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia to human type 2 lyssencephaly. Curr Biol 1999;9:719-27
38. Handler M, Yang X, Shen J. Presenilin-1 regulates neuronal differentiation during neurogenesis. Development 2000;127:2593-606
39. Ye Y, Lukinova N, Fortini ME. Neurogenic phenotypes and altered Notch processing in Drosophila presenilin mutants. Nature 1999;398:525-29
40. Guo Y, Livne-Bar I, Zhou L, Boulianne GL. Drosophila presenilin is required for neuronal differentiation and affects Notch subcellular localization and signaling. J Neurosci 1999;19:8435-42
41. Bugiani O, Giaccone G, Capobianco R, Tagliavini F, Ghetti B. Alzheimer's disease (AD): AT8 recognizes degenerating ectopic neurons and astrocytes in the subcortical white matter. (Abstract) J Neuropathol Exp Neurol 2003;62:547
42. Honavar M, Meldrum BS. Epilepsy. In: Graham DI, Lantos PL, eds. Greenfield's neuropathology. 6th ed. Arnold, 1997:931-37
43. Tabaton M, Cammarata S, Mancardi G, et al. Ultrastructural localization of β-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles. Proc Natl Acad Sci U S A 1991;88:2098-2102
44. Bondareff W, Harrington C, Wischik CM, Hauser DL, Roth M. Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 1994;53:158-64
45. Hyman BT, van Hoesen GW, Beyreuther K, Masters CL. A4 amyloid protein immunoreactivity is present in Alzheimer's disease neurofibrillary tangles. Neurosci Lett 1989;101:325-55
46. Schwab C, Akiyama H, McGeer EG, McGeer PL. Extracellular neurofibrillary tangles are immunopositive for the 40 carboxy-terminal sequence of beta-amyloid protein. J Neuropathol Exp Neurol 1998;57:1131-37